Biotechnology Research in Slovakia

Roche Slovensko

Roche je najväčšia biotechnologická spoločnosť sveta a globálny priekopník v oblasti zdravotnej starostlivosti s viac ako 125 ročnou históriu. Vďaka výrazným investíciám do vedy a výskumu sme úspešní vo vývoji diagnostických postupov a inovatívnych liekov v oblasti onkológie, imunológie, infekčných chorôb, oftalmológie a chorôb centrálneho nervového systému. Sme tiež svetovým lídrom v in vitro diagnostike, aj v tkanivovej diagnostike rakoviny. Staviame na pokroku v molekulárnej biológii i farmakogenetike a čoraz viac približujeme k princípom personalizovanej medicíny. Viac než tridsať liekov vyvinutých spoločnosťou Roche je zaradených do zoznamu základných liekov Svetovej zdravotníckej organizácie, medzi ktoré patria život zachraňujúce antibiotiká, antimalariká a lieky proti rakovine. Už jedenásty rok po sebe patrí Roche k najudržateľnejším spoločnostiam vo farmaceutickom priemysle definovaných prostredníctvom indexov udržateľnosti Dow Jones (DJSI). Naša organizácia so sídlom v Bazileji vo Švajčiarsku pôsobí vo viac, ako 100 krajinách a v roku 2020 celosvetovo zamestnávala viac ako 100 ľudí. Táto webová stránka nie je určená na hlásenie nežiaducich udalostí. Nežiaducu udalosť týkajúcu sa produktu spoločnosti Roche môžete nahlásiť elektronicky zaslaním e-mailu na adresu slovakia.drug_safety@roche.com, telefonicky na číslach +421 2 5263 8201 a +421 905 400 503 (24-hodinová dostupnosť) alebo faxom na čísle +421 2 52 635 015. Bližšie informácie o hlásení nežiaducich udalostí nájdete na Podozrenia na nežiaduce účinky súvisiace s akýmkoľvek produktom môžete hlásiť aj prostredníctvom tlačiva na webovej stránke Štátneho ústavu pre kontrolu liečiv alebo elektronicky https://portal.sukl.sk/eskadra/. Ochrana osobných údajov:

51 to 200 staff

Axon Neuroscience

Axon Neuroscience is a clinical-stage biotechnology leader pioneering tau-targeted therapies to prevent and treat Alzheimer’s disease and related neurodegenerative disorders. Founded in by Prof. Michal Novak, who discovered the tau protein as a key cause of Alzheimer’s disease, Axon has built the world’s largest dedicated tau research team with over 20 senior in-house scientists advancing cutting-edge programs from discovery to clinical development. Axon’s lead candidate, AADvac1, is the most clinically advanced active vaccine targeting pathological tau. In the successful Phase II ADAMANT study, AADvac1 showed excellent safety and immunogenicity, with over 80% of patients developing strong anti-tau antibodies. Axon demonstrated consistent biomarker efficacy across NfL, GFAP, and MRI volumetry, alongside a trending clinical benefit — validating its disease-modifying potential. Building on this foundation, Axon is advancing AADvac1 into two major international platform trials starting in 2026: The Alzheimer’s Tau Platform (ATP) enrolling 375 patients with early Alzheimer’s, evaluating AADvac1 alone and in combination with anti-amyloid antibodies. The Progressive Supranuclear Palsy (PSP) Phase II Platform Trial, enrolling 220 patients, expanding AADvac1’s potential across tauopathies beyond Alzheimer’s. Axon’s diversified pipeline also includes a humanized anti-tau monoclonal antibody (AADvac2), and small-molecule programs targeting tau aggregation and propagation. With over two decades of pioneering science and consistent clinical validation, Axon Neuroscience is transforming the future of brain health with the promise of first-in-class, disease-modifying therapies for millions suffering worldwide.

11 to 50 staff

Seerlinq

Seerlinq is taking non-invasive diagnostics, disease monitoring and treatment optimization to a new level by utilising state-of-the-art machine learning PPG analysis, and our medical expertise. We are reinventing the way of looking at the PPG curve by using artificial intelligence to analyse all measured parameters comprehensively. Furthermore, we are using our worldwide network of physicians and clinical researchers to collect medically labelled data. Our mission is to personalise treatment and diagnostics of cardiovascular diseases by analysing PPG signal with machine learning.

11 to 50 staff

Biomedical Research Center Of The Slovak Academy Of Sciences

Biomedical Research Center of the Slovak Academy of Sciences is the largest Slovak institution devoted to basic and applied research in biomedical sciences. BMC SAS was officially established on January 1st 2016 by merge of four previously independent SAS institutes, namely the Cancer Research Institute (CRI), the Institute of Clinical and Translational Research (ICTR, former Center for Molecular Medicine), the Institute of Experimental Endocrinology (IEE), and the Institute of Virology (IV). The principal mission of this novel research center is to foster research excellence, develop interdisciplinary approaches, and stimulate innovative potential for the improvement of our knowledge on human diseases, its better translation to clinic and more effective practical use for benefit of patients and the entire society. BMC SAS research is focused on understanding metabolic, neuroendocrine, autoimmune and cardiovascular disorders, cancer and infections, and their interrelationships when cooccurring in the same organisms.

201 to 500 staff

Jemo Trading Spol. S R.O

Distributor of analytical testing in food & feed, clinical diagnostics and food ingredients.

1 to 10 staff

Mabpro Therapeutics

Personalized cancer immunotherapy for aggressive hypoxic tumors with blockbuster potential. Our Target Mechanism For Treating Hypoxic Tumors: Carbonic Anhydrase IX (CA IX). Our Mission- to fill the gap in treatment of oncology diseases with poor prognosis- to increase survival rate and bring hope to patients who have undergone different types of therapies without success- to deliver novel therapeutics that match the principle of personalized medicine which will help patients to improve the quality of their lives. Crunchbase

11 to 50 staff

Koppert, S.R.O

Spoločnosť bola založená v roku 1996. Svoju činnosť vykonáva len na Slovensku a svoje výrobky dodáva do mnohých krajín na svete. Od začiatku výroby biologických opeľovačov si spoločnosť udržiava svoje postavenie najväčšieho svetového výrobcu. Vývoj na trhu však prináša zvýšenú konkurenciu a rastúce požiadavky zákazníkov, regulátorov a odbornej verejnosti, na ktoré je neustále potrebné reagovať.

51 to 200 staff

Parkan Crudes

Parkan Crudes buduje regionálny cirkulárny potravinový systém založený na zhodnocovaní nepredaných potravín. Využívame ich ako vstup pre kontrolovaný chov hmyzu, z ktorého vzniká nutrične stabilný a ekonomicky výhodný zdroj hmyzej bielkoviny pre hydinárske krmivá. Tento model znižuje závislosť na dovoze sójovej a rybej múčky, zlepšuje parametre chovu a preukázateľne znižuje environmentálnu stopu produkcie vajec. Prepájame retail, biokonverzné jednotky a hydinárske farmy do jednotného, transparentného reťazca, ktorý umožňuje efektívne nakladanie s potravinovým tokom, stabilné zásobovanie farmárov a overiteľné ESG dáta pre obchodné reťazce. Výsledkom je lokálna produkcia vajec s nižšou uhlíkovou stopou, založená na regionálnych zdrojoch a technológii s nízkymi kapitálovými nárokmi. Parkan Crudes rozvíja tento systém ako škálovateľnú infraštruktúru pripravenú na implementáciu v rámci Slovenska.

1 to 10 staff

Db Biotech

DB Biotech Inc, Kosice, Slovakia, EU is focused on the design and production of high quality rabbit clonal antibodies developed by a novel and proprietary in-vitro cloning technology which has been developed and perfected by the DBB scientific team over a period of 20 years. DB Biotech monospecific clonal antibodies are uniquely characterized by exceptional specificity, affinity and avidity. The DB Biotech in-vitro cloning technology enables the preparation of a pure immunoglobulin fraction corresponding to a single clone of B lymphocytes. The obtained immunoglobulin recognizes only one single linear epitope on the antigen molecule, making a DB Biotech antibody comparable in quality to its monoclonal analogue. In addition, the influence of the protein tertiary structure – frequently present in epitopes formed during production of monoclonal antibodies – is eliminated in the immunoglobulins corresponding to the clonal antibody. DB Biotech produced antibodies correspond strictly to the conserved linear epitope of the antigen molecule, yielding a higher-quality, more specific antibody with significantly better affinity and avidity. Founded in 2006 for business please contact Sales sales@dbbiotech.com or dbbiotech@dbbiotech.com

11 to 50 staff

Genotipo Slovakia

Genotipo was founded to provide independent genetic counseling for individuals seeking a deeper understanding of their genetic testing options, results, and implications for their health care, as well as for their family members.

1 to 10 staff

Genetica Group

GeneTiCA Group is a pioneering force in. With a strong presence across the Czech Republic, Slovakia, and Hungary, our mission is to provide cutting-edge solutions that advance. Our commitment to excellence drives us to be the leading company in our market. We strive to achieve this by offering the highest-quality instruments, reagents, and consumables alongside superior customer service. We aim to empower researchers and healthcare professionals with the necessary tools to make groundbreaking discoveries and improve patient outcomes. We specialize in distributing and supporting NGS and Multiomics instruments and proudly represent industry leaders such as @Illumina. Additionally, we represent renowned brands, including @10x Genomics,@QIAGEN,@Seer, and many others. Our portfolio encompasses a wide range of state-of-the-art instruments, reagents, and consumables designed to meet the diverse needs of the biomedical community. At 🟣 GeneTiCA Group, we take pride in our teams of experts in each country. Our dedicated sales, technical, and application support teams work harmoniously to ensure exceptional customer care across all three countries. This unified approach allows us to deliver unparalleled service and support to our valued clients. We are 🟣 GeneTiCA Group - we are your project partner!

11 to 50 staff

Fermentae

Fermentae is a new international project focused on the diffusion of fermentation processes and some other processes related to it, in three main topics: 1) Food and beverages 2) Energy and environment 3) Health

1 to 10 staff

Kannalab

We work at the intersection of agroecology, material experimentation, and rural development, with a focus on building from farm to fibre value chains in marginal rural regions. In collaboration with Textilné centrum in Košice we explore hemp as an agroecological crop and material resource, connecting cultivation under challenging conditions with local processing, early-stage material experimentation, and design applications. KannaLab operates through applied experimentation: small-scale pilots, collaborative research activities, and concept validation in real-world contexts. We act as a connector between farmers, designers, researchers, and public actors, translating between local practice and European innovation frameworks. Based near Poloniny National Park in Eastern Slovakia, our work is grounded in a region where biodiversity, remoteness, and structural challenges coexist making it a relevant testbed for resilient, place-based innovation models.

1 to 10 staff

Nu3gen

Applying nutritional genomics knowledge to the consumer's everyday life.

1 to 10 staff

Product Comfy

1 to 10 staff

Shealed

1 to 10 staff

Bio-Circle Surface Technology Slovensko

Bio-Circle Surface Technology optimalizuje procesy čistenia, zvárania, mazania a ochrany v rôznych oblastich priemyslu s veľkým dôrazom na bezpečnosť a ekológiu. Nahrádza nebezpečné látky ako sú prchavé organické rozpúšťadlá, aerosólové spreje a iné nebezpečné/horľavé čistiace prostriedky vo výrobe a v údržbe. MAKING GREEN WORK.

1 to 10 staff

Biomedical Engineering, S.R.O

On the basis of medical DICOM data we design, develope and manufacture custom-made non-active functional implants by usage of 3D printing technologies. Individually designed prints from Titanium or special plastics - biocompatible implants, 3D models. Also STL format, industrial tomography and additive technology.

1 to 10 staff

Saftra Photonics

SAFTRA photonics is a Slovak high-tech company established as a spin-off from the P. J. Safarik University, Kosice, Slovakia in 2014. The development and the business strategies of the company are based on the research activities of the group led by prof. Pavol Miskovsky, the head of the Center for Interdisciplinary Biosciences at the P. J. Safarik University, mainly in the fields of photonics and biomedical research. The mission of SAFTRA Photonics lies in providing a wide range of market driven research and development activities in the field of (nano)photonics science and technology transfer primarily focused on testing, analyses and controlling processes applied in medicine, environment, and cultural heritage. The long-term vision of SAFTRA Photonics is based on synergy between research performing in the Center for interdisciplinary biosciences, education in biophysics executed by Department of Biophysics of the P. J. Safarik University and related technology transfer implemented by SAFTRA Photonics. Sharing of the common laboratory space by all three institutions assure a high efficiency of such collaboration and has an important impact even for an economic and social development of the region.

1 to 10 staff

Emma & Nella Technology

We are engaged in the development, manufacture and distribution of air purification equipment. They use unique technologies and are effective against both viruses and pollution.

1 to 10 staff

Eurofins Rblsc It Cee S.R.O

Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and the environment safer, healthier, and more sustainable. From the food you eat to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and their labeling is accurate. Eurofins is a global leader in food, environmental, pharmaceutical, and cosmetic product testing and in agroscience CRO services. It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences, and in the support of clinical studies. In over just 35 years, Eurofins has grown from one laboratory in Nantes, France to over staff across a network of independent companies in 61 countries, operating ca. 900 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialized clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest-growing listed European companies. In 2022, Eurofins recorded revenues of €6,712 million.

11 to 50 staff

Digital Genomics

Our international team performs analysis of NGS data in clinical setting, variant analysis and interpretation and provides bioinformatics support for genetic testing laboratories.

11 to 50 staff